Indianapolis Business Journal

JUNE 30-JULY 6, 2023

Indianapolis-based Eli Lilly and Co. is in the middle of a battle over the future of drug costs as Medicare begins to ramp up a program to negotiate prices with pharmaceutical companies and many in the industry try to derail it or change the terms. John Russell focuses on Lilly's objections to the program. Also in this week's issue, Susan Orr reports that Indianapolis-based Noble Roman’s is battling with one of its largest shareholders over whether its CEO should be replaced on the restaurant company’s board of directors. And Daniel Bradley previews the plan for a split-level roundabout at one of the busiest intersections in Hamilton County.

Front PageBack to Top

Top StoriesBack to Top

Indiana 250: David Johnson

David Johnson led the Central Indiana Corporate Partnership—a coalition of CEOs, foundations and university presidents that operates six industry and talent initiatives—for 10 years before retiring at the end of last year. Under his leadership, CICP formed two new industry initiatives—AgriNovus Indiana for the agbiosciences and Ascend Indiana for workforce and talent—and developed the Indiana […]

Read More

Made in Indiana: Reggae Sangria by Easley Winery

Company history: Easley Winery opened in 1974 as one of the first post-Prohibition commercial wineries in Indiana. Founders Jack and Joan Easley planted their initial vineyards in Crawford County in 1972, one year after the Indiana Small Winery Act made it possible for wineries to sell directly to the public. Mark Easley, son of Jack […]

Read More

FocusBack to Top

OpinionBack to Top